Graphene is a new material expected to revolutionise fields such as medicine and manufacturing with its light, strong and conductive properties.
The company, which has existing partnerships with Dyson and Procter and Gamble, is expected to seek a valuation of £25m, raising £10m for investment in technical development, commercial partnerships and to scale up its graphene production capacity.
“The global appetite for, and interest in, graphene is growing at a rapid pace. We have seen considerable interest from blue-chip businesses which have recognised the advantages of our production process, enabling us to continuously produce graphene cost efficiently on a commercial scale,” said AGM chief executive Jon Mabbitt.
“Admission to Aim will provide the company with the funding for its next phase of development and build our position as a global graphene manufacturer,” added Mabbitt.
N+1 Singer is AGM’s nominated adviser and broker.